======= MARCH6 ======= == Gene Information == * **Official Symbol**: MARCHF6 * **Official Name**: membrane associated ring-CH-type finger 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10299|10299]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60337|O60337]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MARCH6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MARCH6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613297|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: E3 ubiquitin-protein ligase that promotes ubiquitination of DIO2, leading to its degradation. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. May cooperate with UBE2G1. {ECO:0000269|PubMed:15673284, ECO:0000269|PubMed:19651899}. |RINGv| |ER ubiquitin ligase complex| |endoplasmic reticulum mannose trimming| |ubiquitin-specific protease binding| |protein alpha-1,2-demannosylation| |protein demannosylation| |endoplasmic reticulum quality control compartment| |protein deglycosylation| |ubiquitin conjugating enzyme binding| |protein K48-linked ubiquitination| |ubiquitin-dependent ERAD pathway| |ERAD pathway| |integral component of endoplasmic reticulum membrane| |ubiquitin protein ligase activity| |ubiquitin-protein transferase activity| |response to endoplasmic reticulum stress| |protein polyubiquitination| |proteasome-mediated ubiquitin-dependent protein catabolic process| |enzyme binding| |proteasomal protein catabolic process| |glycoprotein metabolic process| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |protein ubiquitination| |protein modification by small protein conjugation| |zinc ion binding| |cellular macromolecule catabolic process| |endoplasmic reticulum membrane| |protein modification by small protein conjugation or removal| |response to organonitrogen compound| |endoplasmic reticulum| |carbohydrate derivative metabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |response to nitrogen compound| |proteolysis| |cellular response to stress| |organic substance catabolic process| |cellular catabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.97| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-2.3| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.8| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.72| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.73| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.83| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.422| Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5999 * **Expression level (log2 read counts)**: 8.49 {{:chemogenomics:nalm6 dist.png?nolink |}}